Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-26 @ 2:32 AM
Study NCT ID:
NCT05176002
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-19
First Post:
2021-11-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
Sponsor:
Fujian Medical University Union Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NIRE UNION
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None